Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
In today’s fast-evolving biotech landscape, choosing the right biotech CRO (Contract Research Organization) can be the single most...
[Sofia, Bulgaria] – Comac Medical is pleased to announce that Steve Angus will be joining Comac Medical as...
Summer brings sunlit days, long evenings, and countless opportunities to enjoy the outdoors. Yet for the pharmaceutical and...